AstraZeneca
AZN
#49
Rank
HK$2.247 T
Marketcap
HK$724.78
Share price
0.19%
Change (1 day)
33.36%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$23.66

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$23.71. In 2024 the company made an earnings per share (EPS) of HK$17.73 an increase over its 2023 EPS that were of HK$15.00.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.6633.41%
2024HK$17.7318.23%
2023HK$15.0081.13%
2022HK$8.28631.03%
2021HK$1.13-88.11%
2020HK$9.53136.89%
2019HK$4.02-39.41%
2018HK$6.64-28.27%
2017HK$9.26-14.37%
2016HK$10.8124.11%
2015HK$8.71127.55%
2014HK$3.83-51.96%
2013HK$7.97-58.95%
2012HK$19.41-32.2%
2011HK$28.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.50 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.95 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.95 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.86 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.20-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.09 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK